Momenta Pharmaceuticals, Inc. (MNTA)

[RockRat]

Thanks. I've been looking at several companies' partnering possibilities lately and can't quite keep 'em straight. I would have had to slog back through this recent thread to find that again. Anyhow, so far as I can tell, the hyper-sialylation tech seems to be part of their biosimilar IP. Specifically, in the 2014 "methods of cell culture" applications. #s 20140271622 , 20140273057 , 20140274911 , and 20140274912 . Paste these numbers into the patent application search by number engine to see for yourself.

application search by number

You probably really only need to look at one, since they seem to be about the same methods, except with different substrates.

Regards, RockRat